BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Ivera Medical Corporation Announces Patent Award for Curos® Port Protectors


6/13/2012 10:31:18 AM

SAN DIEGO, June 13, 2012 /PRNewswire/ -- Ivera Medical Corporation announced today that the United States Patent & Trademark Office (USPTO) will issue a new continuation patent for its innovative Curos® disinfecting port protector technology on June 26, 2012. U.S. Patent No. 8,206,514 will cover key aspects of disinfecting caps designed to be used with luer-activated IV valves to disinfect and clean the IV port.

IV therapy is the primary route for drug therapy in the acute care setting. However, traditional IV access management techniques, including "scrub the hub" protocols have failed to protect patients as evidenced by the approximately 87 percent of bloodstream infections associated with the presence of some type of intravascular device.

Ivera Medical's Curos Port Protector is a simple, innovative, disposable medical device that effectively disinfects luer-activated needleless valves, killing the organisms associated with patient bloodstream infection. With two dispenser optionsthe Curos Strip or individual Curosnurses can conveniently comply with disinfection protocols by simply peeling the foil seal off the distinctive green cap and twisting Curos over the top of any luer-activated IV access port or needleless valve. Inside Curos a 70% IPA (isopropyl alcohol) saturated sponge-like foam automatically provides effective, consistent and reliable passive disinfection of the port. The use of Curos eliminates training and technique-related issues while providing an unequivocal indicator that an IV access site is clean.

"This patent further strengthens our patent protection within the disinfection cap arena," stated Bob Rogers, chief executive officer of Ivera Medical. "We continue to develop our intellectual property to ensure that Ivera is well-positioned to bring new and better disinfection solutions to market."

About Ivera Medical

Ivera Medical Corporation is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos®, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at http://www.iveramed.com.

Contact:
Bob Rogers
Chief Executive Officer
Ivera Medical Corp.
Bob.rogers@iveramed.com
760-612-6090

SOURCE Ivera Medical Corporation


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->